Figure 2From: Relationship between abnormal osteoblasts and cellular immunity in multiple myelomaVon Kossa staining. (a,b) The depositions of MM patients were less than those of normal controls tested by Von Kossa staining. (c) The depositions of MM patients was less than those of normal controls (*P < 0.01). The calcium depositions in MM osteoblasts with bortezomib were more than those without bortezomib (*P < 0.01), less than those in normal controls (*P < 0.01).Back to article page